Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Nagpur, India | Makes it and packages it | Problems found, fixed voluntarilySep 16, 2025 · 1 inspection |
Recalls
- Apr 24, 2026 · Class II · Lupin Pharmaceuticals Inc.
Presence of particulate matter: a white thread-like structure in the cartridge
Lots: Lots: a) WB00097, WB00094, WB00088, Expires: Jul. 2027; WB00103, Expires: Oct. 2027; WC00016, Expires: Dec. 2027; b) WB00098, WB00092, WB00093, Expires: Jul. 2027; WB00104, WB00106, WB00105, Expires: Oct. 2027.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Liraglutide: every company that makes it
- Form
- injection, subcutaneous
- Strength
- 6 mg per 1 mL
- Approval
- ANDA ANDA215421
- On the market since
- Oct 2, 2025
- Package NDCs
70748-346-0270748-346-03- Official label
- DailyMed (National Library of Medicine), updated Oct 30, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?